Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia.
Waled BahajTariq KewanCarmelo GurnariArda DurmazBen PonvilawanIshani PanditYasuo KubotaOlisaemeka D OgbueMisam ZawitYazan MadanatTaha BatSuresh K BalasubramanianHussein AwadaRamsha AhmedMinako MoriManja MeggendorferTorsten HaferlachValeria VisconteJaroslaw P MaciejewskiPublished in: Journal of hematology & oncology (2023)
Our novel approach more accurately resolves TP53 genomic configuration and uncovers genetic mosaicism for the use in the clinical setting to improve prognostic evaluation.